Company intelligence / Profile preview

Lymphatica Medtech

Lausanne, Vaud, Switzerlandlymphaticamedtech.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

The company has completed a first-in-human clinical trial with nine patients implanted with the device. Initial results show feasibility and safety of the implantable system for chronic lymphedema. The product has received FDA Breakthrough Device Designation and continues to advance through further clinical validation.

Therapeutic areas: Oncology
Modalities: DeviceImplantable medical device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Lymphatica Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatica Medtech.

Explore the full profile